Health / Medical Topics

    Tumor-homing Peptide iRGD

    A 9 amino acid-based cyclic, tumor specific homing, arginine-glycine-aspartic acid (RGD)-based peptide (CRGDKRGPDC), with tumor penetrating activity. The iRGD contains the RGD motif as well as the C-terminal end binding (CendR) motif that increases internalization. Upon administration, the RGD motif of the iRGD peptide is able to specifically target tumors by binding to alphavbeta3/alphavbeta5 integrins on tumor endothelium. In turn, iRGD is cleaved by specific tumor proteases, which exposes the positively charged CendR motif. This motif binds to neuropilin-1 (NRP-1), a receptor overexpressed on certain tumor cells. This increases vascular permeability of tumor blood vessels and promotes tumor penetration. Compared to other RGD peptides, this agent is able to both improve delivery and increase the accumulation of co-administered or conjugated chemotherapeutic agents in the tumor. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    Taken from an individual's own tumor tissue; may be used in the development of a vaccine that enhances the body's ability to…
    A synthetic 14-amino acid peptide derived from a novel human peptide hormone, Tumor-Cells Apoptosis Factor (TCApF), with potential antineoplastic activity. Upon intravenous…
    New blood vessels formed by solid tumors.
    An event, process, or condition that supports, or results from, tumor development.
    Expressed in placenta by human TACSTD2 Gene (GA733 Family), 323-aa 36-kDa (precursor) type I membrane protein Tumor-Associated Calcium Signal Transducer 2 contains…
    A novel tumor-associated carbohydrate epitope identified by the 43-9F monoclonal antibody and associated with the growth pattern of squamous cell lung…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact